---
figid: PMC11034512__DDDT-18-1265-g0007
pmcid: PMC11034512
image_filename: DDDT-18-1265-g0007.jpg
figure_link: /pmc/articles/PMC11034512/figure/f0007/
number: Figure 7
figure_title: ''
caption: 'ML385 reversed the analgesic effect of OB in CFA mice. ML385 was intraperitoneal
  administrated 2 hour before OB administration. (A) Mechanical pain sensitivity and
  (B) thermal pain sensitivity were conducted at baseline and 1, 3, and 5 days after
  CFA injection. **P < 0.01 vs the control group. #P, ##P < 0.01 vs CFA group, &&P
  < 0.01 vs the CFA+OB group, n= 7 per group.'
article_title: Obacunone Alleviates Inflammatory Pain by Promoting M2 Microglial Polarization
  and by Activating Nrf2/HO-1 Signaling Pathway.
citation: Fubei Nan, et al. Drug Des Devel Ther. 2024;18:1265-1275.
year: '2024'

doi: 10.2147/DDDT.S451281
journal_title: Drug Design, Development and Therapy
journal_nlm_ta: Drug Des Devel Ther
publisher_name: Dove

keywords:
- inflammatory pain
- obacunone
- Nrf2
- HO-1

---
